The healthcare world is observing a major shift in diabetes treatment with the introduction of GLP-1 patches. These patches offer a seemingly more user-friendly alternative to subcutaneous administrations of GLP-1 receptor agonists, lessening the requirement of daily needle pricks. The innovation releases the drug directly through the skin, possibl